Primary mediastinal synovial sarcoma in an infant: A case report

Şule Çalışkan Kamış, Begül Yağcı
{"title":"Primary mediastinal synovial sarcoma in an infant: A case report","authors":"Şule Çalışkan Kamış,&nbsp;Begül Yağcı","doi":"10.1002/msp2.70017","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Primary mediastinal synovial sarcoma (PMSS) is an uncommon and aggressive soft tissue tumor, particularly rare in infants. Its diagnosis is challenging due to overlapping features with other thoracic neoplasms and requires integration of histopathology, immunohistochemistry, and molecular genetics.</p>\n </section>\n \n <section>\n \n <h3> Case presentation</h3>\n \n <p>We present a case of a 4-month-old girl admitted with respiratory distress and found to have a large posterior mediastinal mass. Histopathology and immunohistochemistry were compatible with biphasic synovial sarcoma. However, molecular confirmation via detection of <i>SS18-SSX</i> fusion was not performed. Despite multimodal chemotherapy, the tumor progressed, and complete surgical resection was unachievable. The patient died during follow-up in the pediatric intensive care unit.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Accurate diagnosis is critically dependent on <i>SS18-SSX</i> molecular testing, particularly in infants. Incomplete resection and lack of genetic confirmation may contribute to poor prognosis. Literature supports that complete resection is the only consistent predictor of survival. This case illustrates the limitations and consequences of managing PMSS without molecular confirmation or complete resection. A multidisciplinary approach with current diagnostic standards is essential in these high-risk pediatric tumors.</p>\n </section>\n </div>","PeriodicalId":100882,"journal":{"name":"Malignancy Spectrum","volume":"2 3","pages":"163-166"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/msp2.70017","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malignancy Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/msp2.70017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Primary mediastinal synovial sarcoma (PMSS) is an uncommon and aggressive soft tissue tumor, particularly rare in infants. Its diagnosis is challenging due to overlapping features with other thoracic neoplasms and requires integration of histopathology, immunohistochemistry, and molecular genetics.

Case presentation

We present a case of a 4-month-old girl admitted with respiratory distress and found to have a large posterior mediastinal mass. Histopathology and immunohistochemistry were compatible with biphasic synovial sarcoma. However, molecular confirmation via detection of SS18-SSX fusion was not performed. Despite multimodal chemotherapy, the tumor progressed, and complete surgical resection was unachievable. The patient died during follow-up in the pediatric intensive care unit.

Conclusion

Accurate diagnosis is critically dependent on SS18-SSX molecular testing, particularly in infants. Incomplete resection and lack of genetic confirmation may contribute to poor prognosis. Literature supports that complete resection is the only consistent predictor of survival. This case illustrates the limitations and consequences of managing PMSS without molecular confirmation or complete resection. A multidisciplinary approach with current diagnostic standards is essential in these high-risk pediatric tumors.

Abstract Image

婴儿原发性纵隔滑膜肉瘤1例
背景:原发性纵隔滑膜肉瘤(PMSS)是一种罕见的侵袭性软组织肿瘤,在婴儿中尤为罕见。由于与其他胸部肿瘤的特征重叠,其诊断具有挑战性,需要结合组织病理学、免疫组织化学和分子遗传学。我们提出一个病例4个月大的女婴入院呼吸窘迫,发现有一个大的后纵隔肿块。组织病理学和免疫组化与双期滑膜肉瘤一致。然而,没有通过检测SS18-SSX融合来进行分子确认。尽管多模式化疗,肿瘤进展,完全手术切除是无法实现的。患者在儿科重症监护病房随访期间死亡。结论SS18-SSX分子检测对诊断的准确性至关重要,尤其是对婴幼儿。不完全切除和缺乏基因确认可能导致预后不良。文献支持完全切除是唯一一致的生存预测指标。这个病例说明了在没有分子确认或完全切除的情况下管理PMSS的局限性和后果。在这些高危儿童肿瘤中,采用当前诊断标准的多学科方法是必不可少的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信